By 2030, it is projected that most Americans will be overweight, and of those, nearly 50% of adults will be obese. Although the majority of Americans are aware that obesity can have adverse health consequences, survey findings show that few are aware that it can increase cancer risk.
The link between weight and cancer may not be linear, yet large-scale epidemiologic studies have demonstrated a consistent and compelling association between the risk for cancer development and obesity, as defined by body mass index (BMI).
Studies also show that obesity decreases lifespan by up to 8 years and is linked to at least 236 other medical problems, including 13 types of cancer (Table).
Table. Cancers Related to Obesity
Gastrointestinal (GI) Cancers |
Other Cancers |
Esophageal adenocarcinoma |
Breast (menopausal women) |
Colon and rectal |
Uterine |
Gallbladder |
Renal |
Gastric |
Ovarian |
Liver |
Thyroid |
Pancreatic |
Meningioma |
|
Multiple myeloma |
The complex manner in which obesity drives cancer risk was previously highlighted in a reviewThe authors noted that chronic inflammation is a characteristic of obesity and a known mediator of cancer. Obesity-induced inflammation adds additional cancer risk via multiple mechanisms of adipose dysfunction and increased proinflammatory factors. Dysregulation of leptin, adiponectin, and chemokines results in cancer microenvironment changes to enhance protumoral consequences. Additionally,
COMMENTARY
GI Cancer and Obesity: Fighting One Means Addressing the Other
Vicki M. Shah, PA-C, DMSc, MMS; Nancy Reau, MD
DisclosuresOctober 06, 2021
By 2030, it is projected that most Americans will be overweight, and of those, nearly 50% of adults will be obese. Although the majority of Americans are aware that obesity can have adverse health consequences, survey findings show that few are aware that it can increase cancer risk.
The link between weight and cancer may not be linear, yet large-scale epidemiologic studies have demonstrated a consistent and compelling association between the risk for cancer development and obesity, as defined by body mass index (BMI).
Studies also show that obesity decreases lifespan by up to 8 years and is linked to at least 236 other medical problems, including 13 types of cancer (Table).
Table. Cancers Related to Obesity
Gastrointestinal (GI) Cancers
Other Cancers
Esophageal adenocarcinoma
Breast (menopausal women)
Colon and rectal
Uterine
Gallbladder
Renal
Gastric
Ovarian
Liver
Thyroid
Pancreatic
Meningioma
Multiple myeloma
The complex manner in which obesity drives cancer risk was previously highlighted in a reviewThe authors noted that chronic inflammation is a characteristic of obesity and a known mediator of cancer. Obesity-induced inflammation adds additional cancer risk via multiple mechanisms of adipose dysfunction and increased proinflammatory factors. Dysregulation of leptin, adiponectin, and chemokines results in cancer microenvironment changes to enhance protumoral consequences. Additionally,
Medscape Gastroenterology © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Vicki M. Shah, Nancy S. Reau. GI Cancer and Obesity: Fighting One Means Addressing the Other - Medscape - Oct 06, 2021.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Vicki M. Shah, PA-C, DMSc, MMS
Lead Advanced Practice Provider for Solid Organ Transplant, Department of Hepatology, Rush University, Chicago, Illinois
Disclosure: Vicki M. Shah, PA-C, DMSc, MMS, has disclosed no relevant financial relationships.
Nancy S. Reau, MD
Professor, Department of Internal Medicine, Rush University; Richard B. Capps Chair of Hepatology; Section Chief, Hepatology; Associate Director of Organ Transplantation, Rush University Medical Center, Chicago Illinois
Disclosure: Nancy Reau, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie; Gilead; Arbutus; Intercept; Salix
Received research grant from: AbbVie; Gilead
Received income in an amount equal to or greater than $250 from: AASLD